Assessment of quality of life outcomes in the treatment of advanced colorectal malignancies

Gastroenterology Clinics of North America
Imran HassanJeff A Sloan

Abstract

QOL assessment in oncology has made great strides in recent years. There was a difficult time initially, during which QOL tools were "thrown in" to many clinical trials as an afterthought, without a pre-specified scientific question. As expected from such a scattershot approach, the results were underwhelming and disappointing. The disappointing results from this period led many practitioners to question the value added by QOL assessment in oncology clinical trials. This healthy skepticism has led to a renaissance period, in which situation-specific and disease-specific QOL assessments have been developed and have contributed substantial information to the cause of the disease, the effects of treatments, and the experiences of cancer patients. Today, there is a dawning recognition that asking the patient directly about their QOL using the same scientific rigor required of other clinical outcomes can provide valuable data for prognosis, treatment, symptom management, and supportive care. With time and further successful experiences like those cited in this article, QOL assessment may eventually become as routinely collected and integrated into oncology clinical practice as pain and blood pressure assessments are today.

References

Dec 1, 1995·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·B R FerrellM Grant
Jan 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P M FayersR Stephens
Apr 17, 1998·The American Journal of Hospice & Palliative Care·N M Ellison
Sep 16, 1999·International Journal of Radiation Oncology, Biology, Physics·G H MannaertsH J Rutten
Apr 29, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J de HaesA Cull
Jan 13, 2001·Diseases of the Colon and Rectum·A R MillerJ M Skibber
Feb 13, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·K LindelM Ancukiewicz
Jul 27, 2001·Journal of Surgical Oncology·G F Whalen, C E Ferrans
May 11, 2002·Diseases of the Colon and Rectum·Margo ShoupBruce D Minsky
Nov 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nestor F EsnaolaJohn M Skibber
May 2, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy F KozelskyUNKNOWN North Central Cancer Treatment Group
Aug 7, 2003·Journal of the National Cancer Institute·Donald L PatrickUNKNOWN National Institutes of Health State-of-the-Science Panel
Aug 29, 2003·Lancet·Karin AhlbergVictoria Mock
Mar 3, 2004·Surgical Oncology Clinics of North America·Dieter HahnloserHeidi Nelson
Jul 9, 2004·Surgical Oncology Clinics of North America·Farin AmersiClifford Y Ko
Oct 9, 2004·Journal of Pain and Symptom Management·Bart H P OsseRichard P T M Grol
Dec 23, 2004·Surgery·Michael HünerbeinPeter M Schlag
Jan 22, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·David OsobaUNKNOWN Quality of Life Committee of the NCIC CTG
Oct 1, 2004·Expert Review of Pharmacoeconomics & Outcomes Research·Geoffrey R NormanKathleen W Wyrwich

❮ Previous
Next ❯

Citations

Feb 8, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Mellar P Davis, Jordanka Kirkova
Sep 6, 2006·Gastroenterology Clinics of North America·Arthur F StucchiJames M Becker
Mar 2, 2011·Oncology Nursing Forum·Clara Granda-CameronArlene Houldin
Oct 24, 2007·Journal of the National Cancer Institute. Monographs·Edwin P RockLaurie B Burke
Dec 28, 2006·Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy·Pasquale SpinelliXiao-Guang Ni
Mar 31, 2015·Conservation Biology : the Journal of the Society for Conservation Biology·David A Eads, Dean E Biggins
Aug 19, 2010·Expert Review of Pharmacoeconomics & Outcomes Research·Yanni Hao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Vascular and Interventional Radiology : JVIR
Michael A Choti
The New England Journal of Medicine
Jeffrey A Meyerhardt, Robert J Mayer
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
Paris P TekkisA W Darzi
© 2021 Meta ULC. All rights reserved